NEW YORK (GenomeWeb News) – McGill University researchers have received more than C$5 million ($4.9 million) in funding to launch a project that will seek to develop genetic biomarkers for use in treating and improving the quality of life in children with brain cancer, McGill said yesterday.

The researchers plan to develop and deploy a diagnostic test in clinical trials that identifies genetic mutations in glioblastoma patients that could be used to plan treatment strategies and improve quality of life.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.